Invivo Therapeutics Holdings 's

• NVIV's Stock Performance relative to its Competitors

Blueprint Medicines Corporation Share Performance +48.51% This Year

Blueprint Medicines Corporation Profile The business model of Blueprint Medicines Corporation revolves around the development and commercialization of precision therapies for patients with genomically defined cancers and rare diseases. They actively pursue a strategy of genomically targeted drug discovery and development, utilizing advanced technologies and clinical expertise to bring potentially life-changing treatments to market. The company focuses on creating value through strategic collaborations, licensing agreements, and the commercialization of their innovative therapies. More about Blueprint Medicines Corporation's Market Share

Sanuwave Health Inc Share Performance +11.49% Over The Past 5 Days

Sanuwave Health Inc Profile Sanuwave Health Inc operates through a business model centered on developing and commercializing innovative regenerative medicine technologies. The company focuses on creating noninvasive, nonthermal, and durable ultrasound therapeutic devices to treat various medical conditions. Sanuwave Health Inc primarily generates revenue by selling its products and securing licensing agreements with healthcare providers and distributors. More about Sanuwave Health Inc 's Market Share

Regenxbio Inc Share Performance -44.73% This Year

Regenxbio Inc Profile Regenxbio Inc is a biotechnology company that focuses on the development and commercialization of gene therapy treatments for various diseases. Their business model revolves around leveraging their proprietary gene delivery platform, NAV Technology, to license their technology and collaborate with other pharmaceutical companies to advance gene therapy programs. They generate revenue through licensing agreements, milestone payments, and royalties from their partners, while retaining the rights to develop their own internal pipeline of therapies. More about Regenxbio Inc 's Market Share

Pavmed Inc Share Performance -21.81% 30 Days

Pavmed Inc Profile Pavmed Inc is a medical device company that focuses on developing and commercializing innovative products for various medical fields. The company's business model revolves around identifying unmet medical needs, acquiring proprietary rights to potential products, and advancing them through development stages to obtain regulatory approvals and market them. More about Pavmed Inc 's Market Share

Intellia Therapeutics Inc Share Performance +7.31% Over The Past 5 Days

Intellia Therapeutics Inc Profile Intellia Therapeutics Inc is a biotechnology company focused on developing therapies based on CRISPR/Cas9 gene editing technology. More about Intellia Therapeutics Inc 's Market Share

Sources: Invivo Therapeutics Holdings Corp’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Sunday, September 13, 2026 11:25 PM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Invivo Therapeutics Holdings Corp versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.